Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81323306 | 8132330 | 6 | F | 2011 | 20160901 | 20110913 | 20160909 | EXP | US-AMGEN-USASP2011045612 | AMGEN | 70.00 | YR | E | M | Y | 0.00000 | 20160909 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81323306 | 8132330 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 1024364 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||
| 81323306 | 8132330 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 1046679 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 81323306 | 8132330 | 3 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 1051222 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 81323306 | 8132330 | 4 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 1067265 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 81323306 | 8132330 | 5 | SS | LEVSIN | HYOSCYAMINE SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 81323306 | 8132330 | 6 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 81323306 | 8132330 | 7 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 81323306 | 8132330 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | 800 MUG, DAILY | 0 | 800 | UG | TABLET | ||||||||
| 81323306 | 8132330 | 9 | C | CIALIS | TADALAFIL | 1 | Oral | 20 MG EVERY DAY AS NEEDED | 0 | 20 | MG | TABLET | |||||||
| 81323306 | 8132330 | 10 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | 2 MG, AT BEDTIME | 0 | 2 | MG | CAPSULE | ||||||||
| 81323306 | 8132330 | 11 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 0.25 MG, DAILY | 0 | .25 | MG | TABLET | |||||||
| 81323306 | 8132330 | 12 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | Sublingual | 0.4 MG, UNK | 0 | .4 | MG | SUBLINGUAL TABLET | |||||||
| 81323306 | 8132330 | 13 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, BID | 0 | 20 | MG | TABLET | BID | |||||||
| 81323306 | 8132330 | 14 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, UNK | 0 | 5 | MG | TABLET | |||||||
| 81323306 | 8132330 | 15 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40 MG, QD | 0 | 40 | MG | TABLET | QD | ||||||
| 81323306 | 8132330 | 16 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | 200 MG, DAILY | 0 | 200 | MG | TABLET | ||||||||
| 81323306 | 8132330 | 17 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 1000 MUG, QD | 0 | 1000 | UG | TABLET | QD | |||||||
| 81323306 | 8132330 | 18 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | 0 | 75 | MG | TABLET | QD | ||||||
| 81323306 | 8132330 | 19 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 15 MG, AT BED TIME | 0 | 15 | MG | CAPSULE | QD | |||||||
| 81323306 | 8132330 | 20 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK UNK, QID | 0 | TABLET | QID | |||||||||
| 81323306 | 8132330 | 21 | C | KEPPRA | LEVETIRACETAM | 1 | Oral | 500 MG, BID | 0 | 500 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 81323306 | 8132330 | 1 | Rheumatoid arthritis |
| 81323306 | 8132330 | 5 | Seizure |
| 81323306 | 8132330 | 6 | Cerebrovascular accident |
| 81323306 | 8132330 | 7 | Myocardial infarction |
| 81323306 | 8132330 | 12 | Chest pain |
| 81323306 | 8132330 | 20 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 81323306 | 8132330 | HO |
| 81323306 | 8132330 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 81323306 | 8132330 | Adhesion | |
| 81323306 | 8132330 | Arteriosclerosis coronary artery | |
| 81323306 | 8132330 | Arthralgia | |
| 81323306 | 8132330 | Benign prostatic hyperplasia | |
| 81323306 | 8132330 | Brain neoplasm | |
| 81323306 | 8132330 | Cardiac pacemaker insertion | |
| 81323306 | 8132330 | Cardiomyopathy | |
| 81323306 | 8132330 | Cerebral artery occlusion | |
| 81323306 | 8132330 | Cerebrovascular accident | |
| 81323306 | 8132330 | Dizziness | |
| 81323306 | 8132330 | Eye disorder | |
| 81323306 | 8132330 | Eye pain | |
| 81323306 | 8132330 | Fall | |
| 81323306 | 8132330 | Fatigue | |
| 81323306 | 8132330 | Gait disturbance | |
| 81323306 | 8132330 | Gastrooesophageal reflux disease | |
| 81323306 | 8132330 | Haemorrhage | |
| 81323306 | 8132330 | Hemiplegia | |
| 81323306 | 8132330 | Hyperlipidaemia | |
| 81323306 | 8132330 | Impaired work ability | |
| 81323306 | 8132330 | Implantable defibrillator insertion | |
| 81323306 | 8132330 | Intervertebral disc degeneration | |
| 81323306 | 8132330 | Joint dislocation | |
| 81323306 | 8132330 | Joint range of motion decreased | |
| 81323306 | 8132330 | Joint swelling | |
| 81323306 | 8132330 | Knee arthroplasty | |
| 81323306 | 8132330 | Lacrimation increased | |
| 81323306 | 8132330 | Memory impairment | |
| 81323306 | 8132330 | Meningioma | |
| 81323306 | 8132330 | Myocardial infarction | |
| 81323306 | 8132330 | Osteoarthritis | |
| 81323306 | 8132330 | Pain | |
| 81323306 | 8132330 | Pancreatitis | |
| 81323306 | 8132330 | Pneumonia | |
| 81323306 | 8132330 | Rotator cuff syndrome | |
| 81323306 | 8132330 | Seizure | |
| 81323306 | 8132330 | Spinal operation | |
| 81323306 | 8132330 | Surgery | |
| 81323306 | 8132330 | Upper limb fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 81323306 | 8132330 | 1 | 2004 | 201507 | 0 |